SCHEMBL23706402

SCHEMBL23706402

CO/C=C(\Oc1cc(-c2ccccc2)ccc1C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
MAPT P10636 3/20 0.38
EGFR P00533 2/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.36
HNF4A P41235 1/20 0.36
ACMSD Q8TDX5 1/20 0.36
SLC6A9 P48067 1/20 0.36
MCL1 Q07820 1/20 0.36
KMO O15229 1/20 0.35
ACLY P53396 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423338 0.89 MEN1 (0.39) MEN1KMT2AMAPTEGFRPOLB
SCHEMBL30784639 0.89 MEN1 (0.39) MEN1KMT2AMAPTEGFRPOLB
SCHEMBL31387874 0.89 MEN1 (0.39) MEN1KMT2AMAPTEGFRPOLB
SCHEMBL7783807 0.89 MEN1 (0.39) MEN1KMT2AMAPTEGFRPOLB
SCHEMBL7783810 0.89 MEN1 (0.39) MEN1KMT2AMAPTEGFRPOLB
SCHEMBL23706391 0.89 ESR2 (0.43) MAPTSLC6A9
SCHEMBL23706396 0.85 ERN1 (0.42) ACMSDSLC6A9
SCHEMBL28950918 0.82 TDP1 (0.43) KDM4EALDH1A1PPARG
SCHEMBL21647861 0.80 SMN1; SMN2 (0.37) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL26088876 0.80 ACHE (0.35) MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025223904-A1 MIXTURES OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS WITH AT LEAST ONE FURTHER PESTICIDE I BASF SE (DE) 2025-10-30 WO claimed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US claimed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US claimed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US claimed
WO-2021153759-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD 住友化学株式会社 2021-08-05 WO claimed
WO-2021153758-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD 住友化学株式会社 2021-08-05 WO claimed
WO-2021153760-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD 住友化学株式会社 2021-08-05 WO claimed
WO-2025223904-A1 MIXTURES OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS WITH AT LEAST ONE FURTHER PESTICIDE I BASF SE (DE) 2025-10-30 WO disclosed
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-30 US disclosed
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-03-09 US disclosed
WO-2021153759-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD 住友化学株式会社 2021-08-05 WO disclosed
WO-2021153760-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD 住友化学株式会社 2021-08-05 WO disclosed
WO-2021153758-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD 住友化学株式会社 2021-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230069915-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD MT-CO3, MT-CO2, HADHB MEN1 3716/4885KMT2A 2854/4885MAPT 3412/4885
US-20230130546-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD FASTKD1, MT-CO1, MT-CO2 MEN1 3645/4885KMT2A 1355/4885MAPT 465/4885
US-20230100754-A1 PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD CYP51A1, CTRL, ERG28 MEN1 1688/4885KMT2A 2599/4885MAPT 1024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.